40716-66-3
40716-66-3
Chemical Structure
trans-Nerolidol
- CAS No.: 40716-66-3
- Formula:C15H26O
- Molecular Weight:222.37
IUPAC Name: (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
InChIKey: FQTLCLSUCSAZDY-SDNWHVSQSA-N
SMILES: C=CC(C)(O)CC/C=C(C)/CC/C=C(C)/C
Biological Activity: trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) (HY-15142A) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
trans-Nerolidol | 96.73% | trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) (HY-15142A) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
trans-Nerolidol (Standard) | 94.58% | trans-Nerolidol (Standard) is the analytical standard of trans-Nerolidol. This product is intended for research and analytical applications. trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) (HY-15142A) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
